Clinical Trial Update: A Study Comparing Two Standard of Care Adjuvant Chemotherapy Regimens for Lower Risk HER-2 Positive Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing two standard-of-care adjuvant chemotherapy regimens in lower-risk HER-2 positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Breast Neoplasms | Phase 3 | Status: COMPLETED